Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors.

作者: Helena Escuin-Ordinas , Shuoran Li , Michael W. Xie , Lu Sun , Willy Hugo

DOI: 10.1038/NCOMMS12348

关键词: Wound healingMitogen-activated protein kinase kinaseProtein kinase ACancer researchMedicineKinaseVemurafenibMEK inhibitorMelanomaMAPK/ERK pathway

摘要: BRAF inhibitors are highly effective therapies for the treatment of BRAF(V600)-mutated melanoma, with main toxicity being a variety hyperproliferative skin conditions due to paradoxical activation mitogen-activated protein kinase (MAPK) pathway in wild-type cells. Most these changes improve when MEK inhibitor is co-administered, as it blocks MAPK activation. Here we show how vemurafenib accelerates wound healing by inducing proliferation and migration human keratinocytes through extracellular signal-regulated (ERK) phosphorylation cell cycle progression. Topical two wound-healing mice models cutaneous activation; addition (MEK) reverses benefit vemurafenib-accelerated healing. The same dosing regimen topical does not increase incidence squamous carcinomas mice. Therefore, may have clinical applications accelerating wounds.

参考文章(25)
Kavita Deonarine, Monica C Panelli, Mitchell E Stashower, Ping Jin, Kina Smith, Herbert B Slade, Christopher Norwood, Ena Wang, Francesco M Marincola, David F Stroncek, Gene expression profiling of cutaneous wound healing. Journal of Translational Medicine. ,vol. 5, pp. 11- 11 ,(2007) , 10.1186/1479-5876-5-11
Megan S. Inkeles, Philip O. Scumpia, William R. Swindell, David Lopez, Rosane M.B. Teles, Thomas G. Graeber, Stephan Meller, Bernhard Homey, James T. Elder, Michel Gilliet, Robert L. Modlin, Matteo Pellegrini, Comparison of Molecular Signatures from Multiple Skin Diseases Identifies Mechanisms of Immunopathogenesis Journal of Investigative Dermatology. ,vol. 135, pp. 151- 159 ,(2015) , 10.1038/JID.2014.352
Helena Escuin-Ordinas, Mohammad Atefi, Yong Fu, Ashley Cass, Charles Ng, Rong Rong Huang, Sharona Yashar, Begonya Comin-Anduix, Earl Avramis, Alistair J. Cochran, Richard Marais, Roger S. Lo, Thomas G. Graeber, Harvey R. Herschman, Antoni Ribas, COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors. Molecular Oncology. ,vol. 8, pp. 250- 260 ,(2014) , 10.1016/J.MOLONC.2013.11.005
Giorgos Fitsialos, Anne-Amandine Chassot, Laurent Turchi, Manal A. Dayem, Kevin LeBrigand, Chimène Moreilhon, Guerrino Meneguzzi, Roser Buscà, Bernard Mari, Pascal Barbry, Gilles Ponzio, Transcriptional Signature of Epidermal Keratinocytes Subjected toin VitroScratch Wounding Reveals Selective Roles for ERK1/2, p38, and Phosphatidylinositol 3-Kinase Signaling Pathways Journal of Biological Chemistry. ,vol. 282, pp. 15090- 15102 ,(2007) , 10.1074/JBC.M606094200
Poulikos I. Poulikakos, Chao Zhang, Gideon Bollag, Kevan M. Shokat, Neal Rosen, RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature. ,vol. 464, pp. 427- 430 ,(2010) , 10.1038/NATURE08902
George T. Bowden, John Smith, Allan Balmain, Martin Ramsden, Activation of the mouse cellular Harvey- ras gene in chemically induced benign skin papillomas Nature. ,vol. 307, pp. 658- 660 ,(1984) , 10.1038/307658A0
Erika L Abel, Joe M Angel, Kaoru Kiguchi, John DiGiovanni, Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications Nature Protocols. ,vol. 4, pp. 1350- 1362 ,(2009) , 10.1038/NPROT.2009.120
Mathieu Jacomy, Tommaso Venturini, Sebastien Heymann, Mathieu Bastian, ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software PLoS ONE. ,vol. 9, pp. e98679- 18 ,(2014) , 10.1371/JOURNAL.PONE.0098679
Raphael Gorodetsky, The use of fibrin based matrices and fibrin microbeads (FMB) for cell based tissue regeneration. Expert Opinion on Biological Therapy. ,vol. 8, pp. 1831- 1846 ,(2008) , 10.1517/14712590802494576
Clare A Hall-Jackson, Patrick A Eyers, Philip Cohen, Michel Goedert, F Tom Boyle, Neil Hewitt, Helen Plant, Philip Hedge, Paradoxical activation of Raf by a novel Raf inhibitor. Chemistry & Biology. ,vol. 6, pp. 559- 568 ,(1999) , 10.1016/S1074-5521(99)80088-X